Anemia affects hundreds of millions worldwide, and the supplement market for anemia support is growing fast—online sales jumped 81.4% in 2025. This growth is driven by rising health awareness, policy support, and demand from pregnant women, children, and younger consumers. Traditional iron supplements are being replaced by better-absorbed forms like ferrous glycinate and fumarate, often combined with vitamin C, folic acid, and B12 to boost iron use and red blood cell production. New formats like gummies and oral liquids also make them more appealing. This summary covers anemia basics, key nutrients, and market trends toward more convenient, targeted solutions.
As consumers worldwide place increasing emphasis on preventive health and nutritional management, the health food industry continues to expand into more specialized and targeted categories. Beyond traditional areas such as immune support, beauty nutrition, and bone health, emerging segments addressing specific nutritional needs are gaining strong market attention.
Among these emerging categories, anemia support supplements have become one of the fastest-growing areas. Driven by increasing awareness of nutritional deficiencies, the needs of specific populations, and innovation in supplement formulations, the market is shifting from simple iron supplementation toward comprehensive nutritional solutions designed to improve iron intake, absorption, and utilization.
Anemia remains one of the most common blood disorders worldwide. Understanding its causes, diagnosis, and nutritional management strategies is essential for developing safer and more effective health products.
Anemia Affects Nearly 900 Million People Worldwide, Making It a Significant Health Concern
Anemia is one of the most common disorders of the blood system and represents a global public health challenge. According to Francesco Branca, Director of the Department of Nutrition and Food Safety at the World Health Organization (WHO), approximately 614 million women and 280 million children worldwide are currently affected by anemia, while progress in anemia prevention and control remains limited.
1) Diagnostic Criteria for Anemia
The essence of anemia is a reduction in the red blood cell capacity of peripheral blood below the normal range, resulting in insufficient oxygen-carrying capacity of the blood.
Currently, hemoglobin (Hb) concentration is the primary clinical indicator used for anemia diagnosis. In China, reference standards for populations living at sea level are applied:
- Adult males: hemoglobin concentration <120 g/L
- Non-pregnant adult females: hemoglobin concentration <110 g/L
- Pregnant women: hemoglobin concentration <100 g/L
Individuals with hemoglobin levels below these thresholds may be diagnosed with anemia.
Based on hemoglobin measurements, anemia is clinically classified into four grades:
- Mild anemia: Hemoglobin level between the lower limit of normal and 90 g/L
- Moderate anemia: Hemoglobin level between 60–89 g/L
- Severe anemia: Hemoglobin level between 30–59 g/L
- Extremely severe anemia: Hemoglobin level below 30 g/L
During clinical diagnosis, physicians usually combine routine blood tests with additional indicators, including red blood cell-related parameters, serum iron, ferritin, vitamin B12, and folate levels. These comprehensive evaluations help distinguish different types of anemia, including iron deficiency anemia, megaloblastic anemia, and hemolytic anemia.
2) Treatment and Management of Anemia
Clinical intervention strategies for anemia are developed based on the specific type of anemia, target population, and severity of the condition. In general, anemia management can be divided into three major approaches: medical intervention, nutritional regulation, and daily health maintenance.
Treatment of underlying causes:
Intervention is first directed toward the primary causes of anemia, such as chronic blood loss, gastrointestinal disorders, abnormal hematopoietic function, and chronic infections. Addressing the underlying causes is essential for resolving anemia at its source.
Medication and nutritional supplementation:
For iron deficiency anemia, oral iron supplements are commonly used, often combined with vitamin C to enhance iron absorption. Megaloblastic anemia requires supplementation with folic acid and vitamin B12. More complex conditions, such as aplastic anemia and hemolytic anemia, require specialized medical treatment and professional management.
Health and nutritional support:
For populations with suboptimal nutritional status, individuals with mild anemia, pregnant women, and children, daily dietary adjustments combined with compliant health food products may provide nutritional support. These products can be used as part of long-term nutritional management strategies to help maintain healthy blood and nutritional status.
Growth Exceeding 200%! New Iron Sources Become a Key Market Growth Driver
As anemia becomes increasingly recognized as a widespread health concern and consumer demand for nutritional management continues to rise, traditional single-ingredient iron supplementation is no longer sufficient to meet consumers’ expectations for scientific, convenient, and effective solutions.
The upgrading of high-quality iron sources and the development of scientifically balanced nutritional combinations have become major trends driving the expansion of the anemia support supplement market.
Market data shows that heme iron products, known for their natural origin and efficient utilization, have maintained steady growth of nearly 50% and gained strong recognition in the premium market. Meanwhile, emerging organic iron sources such as ferrous fumarate have demonstrated rapid growth, with year-on-year increases exceeding 200%, making them one of the major growth highlights in the category.
At the formulation level, scientific nutrient combinations have gradually replaced single iron supplementation and become the mainstream approach in product development. Among them, folic acid and vitamin C, two important synergistic nutrients, achieved combined sales exceeding 290 million yuan, demonstrating consumers’ increasing understanding of comprehensive iron supplementation.
As consumer expectations continue to evolve, traditional iron-only products are gradually losing competitiveness. Formulations combining iron with nutrients that support iron absorption and red blood cell formation, together with advanced organic iron sources, have become essential features and key advantages of modern anemia support supplements.
1) Vitamin-Based Nutritional Combinations
The absorption and utilization of iron require the coordinated action of multiple vitamins. Therefore, supplement formulations commonly combine iron with folic acid, vitamin C, and vitamin B12 to improve iron utilization efficiency while providing balanced nutritional support. This combination strategy has become one of the mainstream approaches in current product development.
Folic Acid
Folic acid participates in DNA synthesis and red blood cell formation, making it a key nutrient for preventing and improving megaloblastic anemia.
For pregnant women, adequate folic acid intake not only helps maintain normal blood formation but also reduces the risk of fetal developmental abnormalities. Therefore, folic acid is widely used in maternal and infant iron supplementation products.
In addition, folic acid can work synergistically with iron, further enhancing the overall nutritional support effect of anemia-related formulations.
Vitamin C
Vitamin C can reduce poorly absorbed ferric iron (Fe³⁺) into ferrous iron (Fe²⁺), which is more easily absorbed by the human body, thereby improving iron absorption efficiency.
It may also help reduce gastrointestinal discomfort associated with iron supplementation, including bloating and nausea.
As a classic companion ingredient in iron supplements, vitamin C plays an important role in improving iron utilization and enhancing the overall consumption experience.
Vitamin B12
Vitamin B12 works together with folic acid to support red blood cell formation and maturation. A deficiency of vitamin B12 may also lead to megaloblastic anemia.
For children, older adults, and individuals following vegetarian diets, adding vitamin B12 to iron supplementation formulas can provide more comprehensive nutritional support for blood formation and better meet the needs of different consumer groups.
2) New-Generation Organic Iron Sources
Compared with traditional inorganic iron sources such as ferrous sulfate, organic iron sources offer advantages including higher bioavailability, lower gastrointestinal irritation, and improved taste characteristics.
As a result, they are increasingly becoming preferred ingredients in modern anemia support products, with multiple categories showing strong market growth.
Ferrous Glycinate
Ferrous glycinate is an amino acid chelated iron compound. It utilizes amino acids as carriers to facilitate iron transport and absorption, resulting in better absorption characteristics compared with traditional inorganic iron sources.
This type of iron is gentle on the digestive system and is less likely to cause common discomforts such as nausea and constipation. With relatively mild taste characteristics, ferrous glycinate is suitable for pregnant women, children, and individuals with sensitive digestive systems, making it a commonly used ingredient in premium iron supplementation products.
Ferrous Fumarate
Ferrous fumarate is an organic iron source characterized by its high iron content and excellent physicochemical stability. It provides effective iron supplementation while causing relatively lower gastrointestinal irritation and fewer unpleasant consumption experiences.
At the same time, ferrous fumarate offers a strong balance between effectiveness and cost efficiency, making it widely used in mainstream consumer anemia support supplements.
Ferrous Gluconate
Ferrous gluconate has good iron solubility and extremely low irritation properties. With a mild taste and strong gastrointestinal compatibility, it is particularly suitable for children, older adults, and individuals with weaker nutritional status.
Due to its high safety profile and excellent formulation compatibility, ferrous gluconate is frequently used in innovative dosage forms such as gummies and oral liquids where taste and consumer acceptance are especially important.
Product Application Trends: Combining Vitamins with New Iron Sources
The development of anemia support products is increasingly moving toward differentiated solutions based on different physiological stages and health needs.
For pregnant and breastfeeding women, nutritional enhancement products commonly combine iron with folic acid and vitamin B12. These formulations aim to support both maternal red blood cell formation and fetal neural tube development. This segment represents one of the most mature areas within the market, with product formats mainly including oral liquids and combination tablets.
For daily nutritional management and individuals with suboptimal health conditions, products are generally designed for populations with mild to moderate iron deficiency risks, such as women experiencing menstrual blood loss, individuals following vegetarian diets, or people with high physical energy consumption. These products are typically formulated with moderate iron doses suitable for long-term nutritional maintenance and are often positioned around concepts such as supporting vitality and reducing fatigue.
For children and individuals with difficulty swallowing, product innovation has focused on improving dosage forms and taste experiences. Products are designed in convenient formats that can be chewed without water, while flavor systems are used to mask the metallic taste of iron. These improvements help address challenges such as children’s reluctance to consume supplements and swallowing difficulties among older adults.
For people with sensitive digestive systems, some products achieve gentle and low-irritation positioning by selecting specific iron sources and optimizing delivery formats. These approaches are designed to better meet the needs of consumers who may experience digestive discomfort or constipation when using traditional iron supplements.
References
[1] Zheng Y, Cantley L C. Toward a better understanding of folate metabolism in health and disease. Journal of Experimental Medicine, 2019, 216(2):253-266.
[2] Selhub J, Morris M S, Jacques P F, et al. Folate–vitamin B-12 interaction in relation to cognitive impairment, anemia, and biochemical indicators of vitamin B-12 deficiency. The American Journal of Clinical Nutrition, 2009, 89(2):702S-706S.
[3] Segal R, Baumoehl Y, Elkayam O, et al. Anemia, serum vitamin B12, and folic acid in patients with rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus. Rheumatology International, 2004, 24(1):14-19.
[4] Vreugdenhil G, Wognum A W, Van Eijk H G, et al. Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness. Annals of the Rheumatic Diseases, 1990, 49(2):93-98.
[5] Ghada Z A, Mahfouz M H, Emara I A. Effect of different types of oral iron therapy used for the treatment of iron deficiency anemia and their effects on some hormones and minerals in anemic rats. Journal of American Science, 2010, 6:109-118.
[6] Toblli J E, Cao G, Oliveri L, et al. Effects of iron polymaltose complex, ferrous fumarate and ferrous sulfate treatments in anemic pregnant rats, their fetuses and placentas. Inflammation & Allergy-Drug Targets, 2013, 12(3):190-198.
[7] Jin Y S, Lai J Q, Zhao X F, et al. Evaluation on glycine chelated iron (II) in improving nutritional anemia in rats. Journal of Hygiene Research, 2005, 34(3):344-346.
[8] Jaber L, Rigler S, Taya A, et al. Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy. Journal of Pediatric Hematology/Oncology, 2010, 32(8):585-588.